Cargando…

Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system

PURPOSE: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. MATERIALS AND METHODS: Patterns-of-care in SBRT using RTRT for histologically p...

Descripción completa

Detalles Bibliográficos
Autores principales: Katoh, Norio, Soda, Itaru, Tamamura, Hiroyasu, Takahashi, Shotaro, Uchinami, Yusuke, Ishiyama, Hiromichi, Ota, Kiyotaka, Inoue, Tetsuya, Onimaru, Rikiya, Shibuya, Keiko, Hayakawa, Kazushige, Shirato, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217432/
https://www.ncbi.nlm.nih.gov/pubmed/28057036
http://dx.doi.org/10.1186/s13014-016-0742-3
_version_ 1782492109936263168
author Katoh, Norio
Soda, Itaru
Tamamura, Hiroyasu
Takahashi, Shotaro
Uchinami, Yusuke
Ishiyama, Hiromichi
Ota, Kiyotaka
Inoue, Tetsuya
Onimaru, Rikiya
Shibuya, Keiko
Hayakawa, Kazushige
Shirato, Hiroki
author_facet Katoh, Norio
Soda, Itaru
Tamamura, Hiroyasu
Takahashi, Shotaro
Uchinami, Yusuke
Ishiyama, Hiromichi
Ota, Kiyotaka
Inoue, Tetsuya
Onimaru, Rikiya
Shibuya, Keiko
Hayakawa, Kazushige
Shirato, Hiroki
author_sort Katoh, Norio
collection PubMed
description PURPOSE: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. MATERIALS AND METHODS: Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. RESULTS: From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52–90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (10) at the isocenter using the linear-quadratic model was from 66 Gy to 126 Gy with a median of 106 Gy. With a median follow-up period of 28 months (range 0–127), the overall survival rate for the entire group, for stage IA, and for stage IB + IIA was 75%, 79%, and 65% at 2 years, and 64%, 70%, and 50% at 3 years, respectively. In the multivariate analysis, the favorable predictive factor was female for overall survival. There were no differences between the clinical outcomes at the four institutions. Grade 2, 3, 4, and 5 radiation pneumonitis was experienced by 29 (10.2%), 9 (3.2%), 0, and 0 patients. The subgroup analyses revealed that compared to margins from gross tumor volume (GTV) to planning target volume (PTV) ≥ 10 mm, margins < 10 mm did not worsen the overall survival and local control rates, while reducing the risk of radiation pneumonitis. CONCLUSIONS: This multi-institutional retrospective study showed that the results were consistent with the recent patterns-of-care and patterns-of-outcome analysis of SBRT. A prospective study will be required to evaluate SBRT using a RTRT system with margins from GTV to PTV < 10mm. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-016-0742-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5217432
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52174322017-01-09 Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system Katoh, Norio Soda, Itaru Tamamura, Hiroyasu Takahashi, Shotaro Uchinami, Yusuke Ishiyama, Hiromichi Ota, Kiyotaka Inoue, Tetsuya Onimaru, Rikiya Shibuya, Keiko Hayakawa, Kazushige Shirato, Hiroki Radiat Oncol Research PURPOSE: To investigate the clinical outcomes of stage I and IIA non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiotherapy (SBRT) using a real-time tumor-tracking radiotherapy (RTRT) system. MATERIALS AND METHODS: Patterns-of-care in SBRT using RTRT for histologically proven, peripherally located, stage I and IIA NSCLC was retrospectively investigated in four institutions by an identical clinical report format. Patterns-of-outcomes was also investigated in the same manner. RESULTS: From September 2000 to April 2012, 283 patients with 286 tumors were identified. The median age was 78 years (52–90) and the maximum tumor diameters were 9 to 65 mm with a median of 24 mm. The calculated biologically effective dose (10) at the isocenter using the linear-quadratic model was from 66 Gy to 126 Gy with a median of 106 Gy. With a median follow-up period of 28 months (range 0–127), the overall survival rate for the entire group, for stage IA, and for stage IB + IIA was 75%, 79%, and 65% at 2 years, and 64%, 70%, and 50% at 3 years, respectively. In the multivariate analysis, the favorable predictive factor was female for overall survival. There were no differences between the clinical outcomes at the four institutions. Grade 2, 3, 4, and 5 radiation pneumonitis was experienced by 29 (10.2%), 9 (3.2%), 0, and 0 patients. The subgroup analyses revealed that compared to margins from gross tumor volume (GTV) to planning target volume (PTV) ≥ 10 mm, margins < 10 mm did not worsen the overall survival and local control rates, while reducing the risk of radiation pneumonitis. CONCLUSIONS: This multi-institutional retrospective study showed that the results were consistent with the recent patterns-of-care and patterns-of-outcome analysis of SBRT. A prospective study will be required to evaluate SBRT using a RTRT system with margins from GTV to PTV < 10mm. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13014-016-0742-3) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-05 /pmc/articles/PMC5217432/ /pubmed/28057036 http://dx.doi.org/10.1186/s13014-016-0742-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Katoh, Norio
Soda, Itaru
Tamamura, Hiroyasu
Takahashi, Shotaro
Uchinami, Yusuke
Ishiyama, Hiromichi
Ota, Kiyotaka
Inoue, Tetsuya
Onimaru, Rikiya
Shibuya, Keiko
Hayakawa, Kazushige
Shirato, Hiroki
Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
title Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
title_full Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
title_fullStr Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
title_full_unstemmed Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
title_short Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
title_sort clinical outcomes of stage i and iia non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217432/
https://www.ncbi.nlm.nih.gov/pubmed/28057036
http://dx.doi.org/10.1186/s13014-016-0742-3
work_keys_str_mv AT katohnorio clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT sodaitaru clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT tamamurahiroyasu clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT takahashishotaro clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT uchinamiyusuke clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT ishiyamahiromichi clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT otakiyotaka clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT inouetetsuya clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT onimarurikiya clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT shibuyakeiko clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT hayakawakazushige clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem
AT shiratohiroki clinicaloutcomesofstageiandiianonsmallcelllungcancerpatientstreatedwithstereotacticbodyradiotherapyusingarealtimetumortrackingradiotherapysystem